 | • レポートコード：MRC2-11QY01798 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は静脈内鉄薬のグローバル市場について調査・分析したレポートです。種類別（カルボキシマルトース第二鉄、ショ糖、デキストラン）市場規模、用途別（腎臓内科、婦人科・産科、消化器内科、腫瘍内科、循環器内科、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別静脈内鉄薬の競争状況、市場シェア ・世界の静脈内鉄薬市場：種類別市場規模 2015年-2020年（カルボキシマルトース第二鉄、ショ糖、デキストラン） ・世界の静脈内鉄薬市場：種類別市場規模予測 2021年-2026年（カルボキシマルトース第二鉄、ショ糖、デキストラン） ・世界の静脈内鉄薬市場：用途別市場規模 2015年-2020年（腎臓内科、婦人科・産科、消化器内科、腫瘍内科、循環器内科、その他） ・世界の静脈内鉄薬市場：用途別市場規模予測 2021年-2026年（腎臓内科、婦人科・産科、消化器内科、腫瘍内科、循環器内科、その他） ・北米の静脈内鉄薬市場分析：米国、カナダ ・ヨーロッパの静脈内鉄薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの静脈内鉄薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の静脈内鉄薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの静脈内鉄薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、AMAG Pharmaceuticals、Daiichi Sankyo、Galenica、Pharmacosmos、Nippon Shinyaku、NOXXON Pharma、Rockwell Medical、Sanofi、Wanbang Biopharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.
Treatment with intravenous iron is clearly superior to oral iron and presents several advantages such as faster and higher increase in Hb levels and replenishment of body iron stores. For these reasons, modern formulations of IV iron have emerged as safe and effective alternatives for IDA management.
Market Analysis and Insights: Global Intravenous Iron Drugs Market
The global Intravenous Iron Drugs market size is projected to reach US$ 1494 million by 2026, from US$ 1430.8 million in 2020, at a CAGR of 4.1%% during 2021-2026.
Global Intravenous Iron Drugs Scope and Market Size
Intravenous Iron Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Iron Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Intravenous Iron Drugs market is segmented into
Ferric carboxy maltose
Sucrose
Dextran
Segment by Application, the Intravenous Iron Drugs market is segmented into
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
Regional and Country-level Analysis
The Intravenous Iron Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intravenous Iron Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intravenous Iron Drugs Market Share Analysis
Intravenous Iron Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravenous Iron Drugs business, the date to enter into the Intravenous Iron Drugs market, Intravenous Iron Drugs product introduction, recent developments, etc.
The major vendors covered:
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica
Pharmacosmos
Nippon Shinyaku
NOXXON Pharma
Rockwell Medical
Sanofi
Wanbang Biopharmaceutical
1 Study Coverage
1.1 Intravenous Iron Drugs Product Introduction
1.2 Market Segments
1.3 Key Intravenous Iron Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intravenous Iron Drugs Market Size Growth Rate by Type
1.4.2 Ferric carboxy maltose
1.4.3 Sucrose
1.4.4 Dextran
1.5 Market by Application
1.5.1 Global Intravenous Iron Drugs Market Size Growth Rate by Application
1.5.2 Nephrology
1.5.3 Gynecology & Obstetrics
1.5.4 Gastroenterology
1.5.5 Oncology
1.5.6 Cardiology
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intravenous Iron Drugs Market Size, Estimates and Forecasts
2.1.1 Global Intravenous Iron Drugs Revenue 2015-2026
2.1.2 Global Intravenous Iron Drugs Sales 2015-2026
2.2 Global Intravenous Iron Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Intravenous Iron Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Intravenous Iron Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Intravenous Iron Drugs Competitor Landscape by Players
3.1 Intravenous Iron Drugs Sales by Manufacturers
3.1.1 Intravenous Iron Drugs Sales by Manufacturers (2015-2020)
3.1.2 Intravenous Iron Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Intravenous Iron Drugs Revenue by Manufacturers
3.2.1 Intravenous Iron Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Intravenous Iron Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous Iron Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intravenous Iron Drugs Revenue in 2019
3.2.5 Global Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Intravenous Iron Drugs Price by Manufacturers
3.4 Intravenous Iron Drugs Manufacturing Base Distribution, Product Types
3.4.1 Intravenous Iron Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous Iron Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Intravenous Iron Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Intravenous Iron Drugs Market Size by Type (2015-2020)
4.1.1 Global Intravenous Iron Drugs Sales by Type (2015-2020)
4.1.2 Global Intravenous Iron Drugs Revenue by Type (2015-2020)
4.1.3 Intravenous Iron Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intravenous Iron Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Intravenous Iron Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous Iron Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Intravenous Iron Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intravenous Iron Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Intravenous Iron Drugs Market Size by Application (2015-2020)
5.1.1 Global Intravenous Iron Drugs Sales by Application (2015-2020)
5.1.2 Global Intravenous Iron Drugs Revenue by Application (2015-2020)
5.1.3 Intravenous Iron Drugs Price by Application (2015-2020)
5.2 Intravenous Iron Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Intravenous Iron Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous Iron Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous Iron Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Intravenous Iron Drugs by Country
6.1.1 North America Intravenous Iron Drugs Sales by Country
6.1.2 North America Intravenous Iron Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Intravenous Iron Drugs Market Facts & Figures by Type
6.3 North America Intravenous Iron Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Intravenous Iron Drugs by Country
7.1.1 Europe Intravenous Iron Drugs Sales by Country
7.1.2 Europe Intravenous Iron Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravenous Iron Drugs Market Facts & Figures by Type
7.3 Europe Intravenous Iron Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Intravenous Iron Drugs by Region
8.1.1 Asia Pacific Intravenous Iron Drugs Sales by Region
8.1.2 Asia Pacific Intravenous Iron Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Intravenous Iron Drugs Market Facts & Figures by Type
8.3 Asia Pacific Intravenous Iron Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Intravenous Iron Drugs by Country
9.1.1 Latin America Intravenous Iron Drugs Sales by Country
9.1.2 Latin America Intravenous Iron Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Intravenous Iron Drugs Market Facts & Figures by Type
9.3 Central & South America Intravenous Iron Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Intravenous Iron Drugs by Country
10.1.1 Middle East and Africa Intravenous Iron Drugs Sales by Country
10.1.2 Middle East and Africa Intravenous Iron Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Intravenous Iron Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Intravenous Iron Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Intravenous Iron Drugs Products Offered
11.1.5 Allergan Related Developments
11.2 AMAG Pharmaceuticals
11.2.1 AMAG Pharmaceuticals Corporation Information
11.2.2 AMAG Pharmaceuticals Description and Business Overview
11.2.3 AMAG Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AMAG Pharmaceuticals Intravenous Iron Drugs Products Offered
11.2.5 AMAG Pharmaceuticals Related Developments
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Corporation Information
11.3.2 Daiichi Sankyo Description and Business Overview
11.3.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Daiichi Sankyo Intravenous Iron Drugs Products Offered
11.3.5 Daiichi Sankyo Related Developments
11.4 Galenica
11.4.1 Galenica Corporation Information
11.4.2 Galenica Description and Business Overview
11.4.3 Galenica Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Galenica Intravenous Iron Drugs Products Offered
11.4.5 Galenica Related Developments
11.5 Pharmacosmos
11.5.1 Pharmacosmos Corporation Information
11.5.2 Pharmacosmos Description and Business Overview
11.5.3 Pharmacosmos Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pharmacosmos Intravenous Iron Drugs Products Offered
11.5.5 Pharmacosmos Related Developments
11.6 Nippon Shinyaku
11.6.1 Nippon Shinyaku Corporation Information
11.6.2 Nippon Shinyaku Description and Business Overview
11.6.3 Nippon Shinyaku Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nippon Shinyaku Intravenous Iron Drugs Products Offered
11.6.5 Nippon Shinyaku Related Developments
11.7 NOXXON Pharma
11.7.1 NOXXON Pharma Corporation Information
11.7.2 NOXXON Pharma Description and Business Overview
11.7.3 NOXXON Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 NOXXON Pharma Intravenous Iron Drugs Products Offered
11.7.5 NOXXON Pharma Related Developments
11.8 Rockwell Medical
11.8.1 Rockwell Medical Corporation Information
11.8.2 Rockwell Medical Description and Business Overview
11.8.3 Rockwell Medical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Rockwell Medical Intravenous Iron Drugs Products Offered
11.8.5 Rockwell Medical Related Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Description and Business Overview
11.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Intravenous Iron Drugs Products Offered
11.9.5 Sanofi Related Developments
11.10 Wanbang Biopharmaceutical
11.10.1 Wanbang Biopharmaceutical Corporation Information
11.10.2 Wanbang Biopharmaceutical Description and Business Overview
11.10.3 Wanbang Biopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Wanbang Biopharmaceutical Intravenous Iron Drugs Products Offered
11.10.5 Wanbang Biopharmaceutical Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Intravenous Iron Drugs Products Offered
11.1.5 Allergan Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Intravenous Iron Drugs Market Estimates and Projections by Region
12.1.1 Global Intravenous Iron Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Intravenous Iron Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Intravenous Iron Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Intravenous Iron Drugs Sales Forecast (2021-2026)
12.2.2 North America: Intravenous Iron Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Intravenous Iron Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Intravenous Iron Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Intravenous Iron Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Intravenous Iron Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Intravenous Iron Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Intravenous Iron Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Intravenous Iron Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Intravenous Iron Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Intravenous Iron Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Intravenous Iron Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Intravenous Iron Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Intravenous Iron Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Intravenous Iron Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Intravenous Iron Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Intravenous Iron Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Intravenous Iron Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Intravenous Iron Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Intravenous Iron Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravenous Iron Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Intravenous Iron Drugs Market Segments
Table 2. Ranking of Global Top Intravenous Iron Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intravenous Iron Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Ferric carboxy maltose
Table 5. Major Manufacturers of Sucrose
Table 6. Major Manufacturers of Dextran
Table 7. Global Intravenous Iron Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Intravenous Iron Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Intravenous Iron Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Intravenous Iron Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Intravenous Iron Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Intravenous Iron Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Intravenous Iron Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Intravenous Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Intravenous Iron Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Iron Drugs as of 2019)
Table 16. Intravenous Iron Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Intravenous Iron Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Intravenous Iron Drugs Price (2015-2020) (USD/Unit)
Table 19. Intravenous Iron Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Intravenous Iron Drugs Product Type
Table 21. Date of International Manufacturers Enter into Intravenous Iron Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Intravenous Iron Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Intravenous Iron Drugs Sales Share by Type (2015-2020)
Table 25. Global Intravenous Iron Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Intravenous Iron Drugs Revenue Share by Type (2015-2020)
Table 27. Intravenous Iron Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Intravenous Iron Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Intravenous Iron Drugs Sales Share by Application (2015-2020)
Table 30. North America Intravenous Iron Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Intravenous Iron Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Intravenous Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Intravenous Iron Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Intravenous Iron Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Intravenous Iron Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Intravenous Iron Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Intravenous Iron Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Intravenous Iron Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Intravenous Iron Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Intravenous Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Intravenous Iron Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Intravenous Iron Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Intravenous Iron Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Intravenous Iron Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Intravenous Iron Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Intravenous Iron Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Intravenous Iron Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Intravenous Iron Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Intravenous Iron Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Intravenous Iron Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Intravenous Iron Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Intravenous Iron Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Intravenous Iron Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Intravenous Iron Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Intravenous Iron Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Intravenous Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Intravenous Iron Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Intravenous Iron Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Intravenous Iron Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Intravenous Iron Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Intravenous Iron Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Intravenous Iron Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Intravenous Iron Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Intravenous Iron Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Intravenous Iron Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Application (2015-2020)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Major Businesses
Table 72. Allergan Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Allergan Product
Table 74. Allergan Recent Development
Table 75. AMAG Pharmaceuticals Corporation Information
Table 76. AMAG Pharmaceuticals Description and Major Businesses
Table 77. AMAG Pharmaceuticals Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. AMAG Pharmaceuticals Product
Table 79. AMAG Pharmaceuticals Recent Development
Table 80. Daiichi Sankyo Corporation Information
Table 81. Daiichi Sankyo Description and Major Businesses
Table 82. Daiichi Sankyo Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Daiichi Sankyo Product
Table 84. Daiichi Sankyo Recent Development
Table 85. Galenica Corporation Information
Table 86. Galenica Description and Major Businesses
Table 87. Galenica Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Galenica Product
Table 89. Galenica Recent Development
Table 90. Pharmacosmos Corporation Information
Table 91. Pharmacosmos Description and Major Businesses
Table 92. Pharmacosmos Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pharmacosmos Product
Table 94. Pharmacosmos Recent Development
Table 95. Nippon Shinyaku Corporation Information
Table 96. Nippon Shinyaku Description and Major Businesses
Table 97. Nippon Shinyaku Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Nippon Shinyaku Product
Table 99. Nippon Shinyaku Recent Development
Table 100. NOXXON Pharma Corporation Information
Table 101. NOXXON Pharma Description and Major Businesses
Table 102. NOXXON Pharma Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. NOXXON Pharma Product
Table 104. NOXXON Pharma Recent Development
Table 105. Rockwell Medical Corporation Information
Table 106. Rockwell Medical Description and Major Businesses
Table 107. Rockwell Medical Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Rockwell Medical Product
Table 109. Rockwell Medical Recent Development
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Major Businesses
Table 112. Sanofi Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Sanofi Product
Table 114. Sanofi Recent Development
Table 115. Wanbang Biopharmaceutical Corporation Information
Table 116. Wanbang Biopharmaceutical Description and Major Businesses
Table 117. Wanbang Biopharmaceutical Intravenous Iron Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Wanbang Biopharmaceutical Product
Table 119. Wanbang Biopharmaceutical Recent Development
Table 120. Global Intravenous Iron Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Intravenous Iron Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Intravenous Iron Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Intravenous Iron Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Intravenous Iron Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Intravenous Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Intravenous Iron Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Intravenous Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Intravenous Iron Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Intravenous Iron Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Intravenous Iron Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Intravenous Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Intravenous Iron Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Intravenous Iron Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Intravenous Iron Drugs Players
Table 138. Intravenous Iron Drugs Customers List
Table 139. Intravenous Iron Drugs Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Iron Drugs Product Picture
Figure 2. Global Intravenous Iron Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Ferric carboxy maltose Product Picture
Figure 4. Sucrose Product Picture
Figure 5. Dextran Product Picture
Figure 6. Global Intravenous Iron Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Nephrology
Figure 8. Gynecology & Obstetrics
Figure 9. Gastroenterology
Figure 10. Oncology
Figure 11. Cardiology
Figure 12. Others
Figure 13. Intravenous Iron Drugs Report Years Considered
Figure 14. Global Intravenous Iron Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Intravenous Iron Drugs Sales 2015-2026 (K Units)
Figure 16. Global Intravenous Iron Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Intravenous Iron Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Intravenous Iron Drugs Sales Market Share by Region in 2019
Figure 19. Global Intravenous Iron Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Intravenous Iron Drugs Revenue Market Share by Region in 2019
Figure 21. Global Intravenous Iron Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Intravenous Iron Drugs Revenue in 2019
Figure 23. Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Intravenous Iron Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Intravenous Iron Drugs Sales Market Share by Type in 2019
Figure 26. Global Intravenous Iron Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Intravenous Iron Drugs Revenue Market Share by Type in 2019
Figure 28. Global Intravenous Iron Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Intravenous Iron Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Intravenous Iron Drugs Sales Market Share by Application in 2019
Figure 31. Global Intravenous Iron Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Intravenous Iron Drugs Revenue Market Share by Application in 2019
Figure 33. North America Intravenous Iron Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Intravenous Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Intravenous Iron Drugs Sales Market Share by Country in 2019
Figure 36. North America Intravenous Iron Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Intravenous Iron Drugs Market Share by Type in 2019
Figure 42. North America Intravenous Iron Drugs Market Share by Application in 2019
Figure 43. Europe Intravenous Iron Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Intravenous Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Intravenous Iron Drugs Sales Market Share by Country in 2019
Figure 46. Europe Intravenous Iron Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Intravenous Iron Drugs Market Share by Type in 2019
Figure 58. Europe Intravenous Iron Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Intravenous Iron Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Intravenous Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Intravenous Iron Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Intravenous Iron Drugs Revenue Market Share by Region in 2019
Figure 63. China Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Intravenous Iron Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Intravenous Iron Drugs Market Share by Application in 2019
Figure 87. Latin America Intravenous Iron Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Intravenous Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Intravenous Iron Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Intravenous Iron Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Intravenous Iron Drugs Market Share by Type in 2019
Figure 98. Latin America Intravenous Iron Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Intravenous Iron Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Intravenous Iron Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Intravenous Iron Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Intravenous Iron Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Intravenous Iron Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Intravenous Iron Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Intravenous Iron Drugs Market Share by Application in 2019
Figure 111. North America Intravenous Iron Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Intravenous Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Intravenous Iron Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Intravenous Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Intravenous Iron Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Intravenous Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Intravenous Iron Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Intravenous Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Intravenous Iron Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Intravenous Iron Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
鉄剤の世界市場（～2026年） Iron is required to transport oxygen through haemoglobin in red blood cells (RBCs) and oxidize cells through cytochrome. Iron deficiency is a common cause of anaemia. Iron drugs are used to treat people with iron deficiency. In terms of geographic regions, the North Americas accounted for the major …- 静脈内（IV）鉄剤の世界市場（～2026年） Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal a…
- 静脈内（IV）溶液の世界市場（～2026年） Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products …
- 静脈内免疫グロブリンの世界市場（～2026年） Immunoglobulin therapy is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions. These conditions include primary immunodeficiency, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AID…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…